Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,89 USD | +1,43% | -1,59% | -11,42% |
Vakgebied
Aantal werknemers: 167
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drug Products
100,0
%
| 214 | 100,0 % | 398 | 100,0 % | +85,90% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 214 | 100,0 % | 398 | 100,0 % | +85,90% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Patrick McEnany
FOU | Founder | 77 | 01-01-02 |
Richard Daly
CEO | Chief Executive Officer | 62 | 19-02-15 |
Michael Kalb
DFI | Director of Finance/CFO | 53 | 01/01 |
Stanley Iyadurai
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-18 |
Brian Elsbernd
CMP | Compliance Officer | 60 | 29-02-16 |
Steven Miller
COO | Chief Operating Officer | 62 | 01-04-07 |
Gary Ingenito
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-06-15 |
Charles O'Keeffe
BRD | Director/Board Member | 84 | 01-12-04 |
Mary Coleman
IRC | Investor Relations Contact | - | 16-08-21 |
Preethi Sundaram
PRN | Corporate Officer/Principal | 47 | 06-07-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick McEnany
FOU | Founder | 77 | 01-01-02 |
Donald Denkhaus
BRD | Director/Board Member | 78 | 19-02-15 |
David Tierney
BRD | Director/Board Member | 60 | 01-10-02 |
Charles O'Keeffe
BRD | Director/Board Member | 84 | 01-12-04 |
Richard Daly
CEO | Chief Executive Officer | 62 | 19-02-15 |
Molly Harper
BRD | Director/Board Member | 48 | 29-06-21 |
Tamar Thompson
BRD | Director/Board Member | 50 | 25-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 118 011 092 | 110 678 237 ( 93,79 %) | 0 | 93,79 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 414 688 | 11.21% | 15 345 290 $ |
Bedrijfsgegevens
Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle Suite 801
33134, Coral Gables
+305 420 3200
http://www.catalystpharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,42% | 1,76 mld. | |
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,35 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |
- Beurs
- Aandelen
- Koers CPRX
- Onderneming Catalyst Pharmaceuticals, Inc.